Ortin Global Q2 Results 2026: Net loss ₹0 Cr, Revenue ₹0 Cr
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹0Cr
- Net profit
- −₹0Cr
- Margin
- −900%
Top 10 Pharmaceuticals & Biotechnology companies on management guidance
See the sector's top 10 — free with your mobile number.
Ortin Global Ltd Q2 FY27 key numbers
- Revenue
- Total income for the quarter was Rs 3.90 lakhs compared to Rs 1.40 lakhs in the corresponding quarter of the previous year.
As stated in Ortin Global Ltd's Q2 FY27 results statement · published 12 Nov 2026. Reported figures, not investment advice.
Based on Ortin Global Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
For the quarter ended 30.09.2026, Ortin Global Limited reported:.
From Ortin Global Ltd's Q2 FY27 earnings-call transcript · updated 12 Nov 2026.
How did Ortin Global's revenue grow in the September 2026 quarter?
- For the quarter ended 30.09.2026, Ortin Global Limited reported:
- Net Sales/Income from Operations: Rs 3.14 lakhs
- Corresponding quarter ended 30.09.2025 Net Sales: Rs 1.40 lakhs
2 more points from Ortin Global Ltd's call on revenue
Create a free account to keep reading this call
What happened to Ortin Global's margins in Q2 FY27?
See what Ortin Global Ltd said on profitability & margins — free account, 30 seconds.
What capex is Ortin Global planning?
See what Ortin Global Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Ortin Global raising money or cutting debt?
See what Ortin Global Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Ortin Global's order book?
See what Ortin Global Ltd said on order book & pipeline — free account, 30 seconds.
Ortin Global Ltd — Quarterly revenue & net profit
Ortin Global Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 0 |
| Operating profit (EBITDA) | -0 |
| Operating margin | -900% |
| Profit before tax | -0 |
| Net profit (PAT) | -0 |
| EPS (₹) | -0.33 |
Source: Ortin Global Ltd's results filing to NSE (standalone), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹0 Cr, net loss ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Pharmaceuticals & Biotechnology
- Sun Pharmaceutical Industries Q2 FY27 results
- Divis Laboratories Q2 FY27 resultsRevenue ₹3770 Cr · PAT ₹1,127 Cr
- Torrent Pharmaceuticals Q2 FY27 results
- Laurus Labs Q2 FY27 results
- Zydus Lifesciences Q2 FY27 results
- Dr Reddy's Labs Q2 FY27 resultsCapex ₹186 Cr
- Cipla Q2 FY27 results
- Mankind Pharma Q2 FY27 results
All Q2 FY27 results | Pharmaceuticals & Biotechnology rankings
Continue your research
Others in Pharmaceuticals & Biotechnology this season
- Alkem Lab (Q2 FY27)
Total Revenue from Operations in Q2 FY27: ₹45,520 million, up 13.8% YoY. Key investor presentation takeaways from Alkem Laboratories Ltd's Q2 FY27 investor pres
- Caplin Point Laboratories Ltd (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹629.84 crore, up 17.9% YoY (compared to ₹534.04 crore in Q2 FY26). Key investor presentation takeaways from Caplin Point Labor
- Bal Pharma (Q2 FY27)
Revenue from operations (Consolidated) for Q2 FY 2026-27: ₹8,994.69 lakhs, up from ₹7,402.49 lakhs in Q2 FY 2025-26, reflecting a year-on-year increase of…
- Bafna Pharmaceuticals (Q2 FY27)
INR 3,546.82 Lakhs, approximately 34.4% increase. Key results statement takeaways from Bafna Pharmaceuticals Ltd's Q2 FY27 results statement — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Ortin Global Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Ortin Global Ltd Q2 FY27 results?
For the quarter ended 30.09.2026, Ortin Global Limited reported:.
What is Ortin Global Ltd share price analysis?
Ortin Global Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹11 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Ortin Global Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.